<DOC>
	<DOCNO>NCT02111954</DOCNO>
	<brief_summary>Prostate cancer patient F-18-FCH PET/CT indicate . Ga-68-NODAGA-MJ9 new PET/CT radiotracer aim give complementary information : precise image early localisation recurrence standard imaging</brief_summary>
	<brief_title>Ga-68-NODAGA-MJ9 Compared F-18-FCH PET/CT Prostate Cancer Patients</brief_title>
	<detailed_description>Patient primary relapse prostate cancer F-18-FCH PET/CT indicate propose participate present study . After sign patient inform consent , F-18-FCH Ga-68-NODAGA-MJ9 PET/CT schedule maximum 10 day-interval . No adverse event expect .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age : adult patient Karnofsky : â‰¥ 80 % Patients histologically proven prostate cancer 18Ffluocholine PET/CT indicate primary cancer staging , recurrence increase blood PSA . In order provide detection probability 30 % , blood PSA 0.5 ng / ml post initial curative intent surgery require . Signed informed consent . Lack discernment sign consent form Age &lt; 18 year Patient hormonal treatment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>primary</keyword>
	<keyword>recurrence</keyword>
	<keyword>F-18-FCH PET/CT</keyword>
	<keyword>Ga-68-NODAGA-MJ9 PET/CT</keyword>
</DOC>